Evidence map›Paper›PMID 32282878›Full record

ArticleBrain : a journal of neurology2020

Bi-allelic GAD1 variants cause a neonatal onset syndromic developmental and epileptic encephalopathy.

Nicolas Chatron, Felicitas Becker, Heba Morsy, Miriam Schmidts, Katia Hardies, Beyhan Tuysuz, Sandra Roselli, Maryam Najafi, Dilek Uludag Alkaya, Farah Ashrafzadeh and 21 more

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Brain : a journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Ventral body wall closure: Mechanistic insights from mouse models and translation to human pathology.Developmental dynamics : an official publication of the American Association of Anatomists · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Insights: fear of GAD.FEBS open bio · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 12 countries.

Nicolas ChatronGenetics Department, Lyon University Hospital, Lyon, France.
Felicitas BeckerDepartment of Neurology, University of Ulm, Ulm, Germany.
Heba MorsyHuman Genetics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Miriam SchmidtsGenome Research Division, Human Genetics Department, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.
Katia HardiesNeurogenetics Group, VIB-Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.
Beyhan TuysuzDepartment of Pediatric Genetics, Istanbul University-Cerrahpasa, Medical Faculty, Istanbul, Turkey.
Sandra RoselliDepartment of Pathology, University of Gothenburg, Sahlgrenska University Hospital, Sweden.
Maryam NajafiGenome Research Division, Human Genetics Department, Radboud University Medical Center Nijmegen, Nijmegen, The Netherlands.
Dilek Uludag AlkayaDepartment of Pediatric Genetics, Istanbul University-Cerrahpasa, Medical Faculty, Istanbul, Turkey.
Farah AshrafzadehDepartment of Paediatric Neurology, Ghaem Medical Centre, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Amira NabilHuman Genetics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Tarek OmarPediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Reza MaroofianGenetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Ehsan Ghayoor KarimianiGenetics Research Centre, Molecular and Clinical Sciences Institute, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK.
Haytham HussienPediatrics Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Fernando KokUniversidade de Sao Paulo Faculdade de Medicina, Sao Paulo, SP, Brazil.
Luiza RamosUniversidade de Sao Paulo Faculdade de Medicina, Sao Paulo, SP, Brazil.
Nilay GunesDepartment of Pediatric Genetics, Istanbul University-Cerrahpasa, Medical Faculty, Istanbul, Turkey.
Kaya BilguvarDepartment of Genetics, Yale Center for Genome Analysis (YCGA), Yale University, School of Medicine, New Haven, Connecticut.
Audrey LabalmeGenetics Department, Lyon University Hospital, Lyon, France.
Eudeline AlixGenetics Department, Lyon University Hospital, Lyon, France.
Damien SanlavilleInstitut NeuroMyoGène CNRS UMR 5310 - INSERM U1217 Université de Lyon, Université Claude Bernard Lyon 1, Lyon, France.
Julitta de BellescizeDepartment of Pediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, ERN EpiCARE, University Hospitals of Lyon, Lyon, France.
Anne-Lise PoulatDepartment of Pediatric Neurology, Lyon University Hospital, Lyon, France.
EuroEpinomics-RES consortium AR working group
Ali-Reza MoslemiDepartment of Pathology, University of Gothenburg, Sahlgrenska University Hospital, Sweden.
Holger LercheUniversity of Tübingen, Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, Tübingen, Germany.
Patrick MayLuxemburg Centre for Systems Biomedicine, University of Luxembourg, Belvaux, Luxembourg.
Gaetan LescaGenetics Department, Lyon University Hospital, Lyon, France.
Sarah WeckhuysenNeurogenetics Group, VIB-Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.
Homa TajsharghiSchool of Health Sciences, Division Biomedicine, University of Skovde, Skovde, Sweden.
Alexandria University · EGHospices Civils de Lyon · FRIstanbul University-Cerrahpaşa · TRUniversité Claude Bernard Lyon 1 · FRUniversity of Antwerp · BEHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo · BRRadboud University Nijmegen · NLSahlgrenska University Hospital · SESt George's, University of London · GBERN EpiCARE · FRHertie Institute for Clinical Brain Research · DEMashhad University of Medical Sciences · IRUniversität Ulm · DEUniversity of Luxembourg · LUUniversity of Skövde · SEYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Center for Mendelian GenomicsUM1HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2016 to 2020
$14.8M
NHGRI Genome Sequencing Program Coordinating CenterU24HG008956 · NHGRI · RUTGERS, THE STATE UNIV OF N.J. · PI BUYSKE, STEVEN G, MATISE, TARA C. · 2016 to 2020
$4.9M
NCATS NIH HHS UL1 TR001863NHGRI NIH HHS U24 HG008956NHGRI NIH HHS UM1 HG006504
6 · The paper itself

Abstract

Developmental and epileptic encephalopathies are a heterogeneous group of early-onset epilepsy syndromes dramatically impairing neurodevelopment. Modern genomic technologies have revealed a number of monogenic origins and opened the door to therapeutic hopes. Here we describe a new syndromic developmental and epileptic encephalopathy caused by bi-allelic loss-of-function variants in GAD1, as presented by 11 patients from six independent consanguineous families. Seizure onset occurred in the first 2 months of life in all patients. All 10 patients, from whom early disease history was available, presented with seizure onset in the first month of life, mainly consisting of epileptic spasms or myoclonic seizures. Early EEG showed suppression-burst or pattern of burst attenuation or hypsarrhythmia if only recorded in the post-neonatal period. Eight patients had joint contractures and/or pes equinovarus. Seven patients presented a cleft palate and two also had an omphalocele, reproducing the phenotype of the knockout Gad1-/- mouse model. Four patients died before 4 years of age. GAD1 encodes the glutamate decarboxylase enzyme GAD67, a critical actor of the γ-aminobutyric acid (GABA) metabolism as it catalyses the decarboxylation of glutamic acid to form GABA. Our findings evoke a novel syndrome related to GAD67 deficiency, characterized by the unique association of developmental and epileptic encephalopathies, cleft palate, joint contractures and/or omphalocele.

Indexed as

Abnormalities, MultipleEpileptic SyndromesFemaleGlutamate DecarboxylaseHumansInfant, NewbornMaleMutationPedigreeGlutamate Decarboxylaseglutamate decarboxylase 1arthrogryposiscleft palateGAD1hypsarrhythmiaomphalocelesuppression-burst

Identifiers

PMID32282878
PMCPMC7241960
OpenAlexW3015615950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.